US-Listed Medicinal Chemicals & Botanical Products — Revenue Percentiles
Population: 31 US-listed companies (SIC 2833), most recent complete fiscal year per filer; fiscal year ends 2025-03-31 to 2031-09-25.
| 10th percentile | $320.8k |
|---|
| 25th percentile | $5.0M |
|---|
| Median | $32.7M |
|---|
| 75th percentile | $189.7M |
|---|
| 90th percentile | $916.4M |
|---|
| Mean | $228.5M |
|---|
| Minimum | $0 |
|---|
| Maximum | $1.3B |
|---|
Methodology & sources
Revenue as filed in the most recent complete fiscal year per company (period > 300 days, fiscal year end within the last 18 months); percentiles computed in the database via percentile_cont, never by a model.
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, as of 2031-09-25.
Scope: {"source": "SEC EDGAR: api.mv_sic x api.v_company_financials (as-filed)", "selection": "je Firma das jüngste volle Geschäftsjahr (>300 Tage, Ende in den letzten 18 Monaten); Umsatzband filtert über de
Evidence samples
Query this live via API/MCP (template peer_percentiles); terms: /nutzung. Cite as: FACTANKER, https://factanker.com/industries/sic-2833/revenue